About
Technology
Issues
FAQ
Links
Official Page
Bevacizumab plus irinotecan in recurrent malignant glioma shows high overall survival in a multicenter retrospective pooled series of the Spanish Neuro-Oncology Research Group (GEINO)
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.